|
|
News Breaks | | | | February 1, 2013 | | 09:00 EDT |  | ALKS | Alkermes falls 7%
Alkermes is down 7%, or $1.61, to $21.44 | |
|
News For ALKS From The Last 14 Days Check below for free stories on ALKS the last two weeks. |
|
|
| May 24, 2013 | | 10:04 EDT |  | ALKS | On The Fly: Analyst Downgrade Summary
 Subscribe for More Information | | | 08:36 EDT | | ALKS | Alkermes downgraded to Sell from Neutral at MKM Partners
Subscribe for More Information | | | May 23, 2013 | | 07:08 EDT |  | ALKS | Alkermes changes fiscal year end, sees 9-months EPS 61c-75c
Alkermes has changed its fiscal year-end from March 31 to Dec. 31 and outlined financial expectations for the nine-month period ending Dec. 31, 2013. Alkermes expects total revenues to range from $395M-$425M, and non-GAAP net income to range from $85M-$105M or 61c-75c per share, for the nine months ending Dec. 31, 2013. Following the change in the company’s financial year-end, the company expects total pro forma revenues for the calendar year ending Dec. 31, 2013, to range from $558M-$588M and expects pro forma non-GAAP net income for the calendar year ending Dec. 31, 2013, to range from $141M-$161M. | | | 07:03 EDT |  | ALKS | Alkermes reports Q4 EPS 40c, may not compare to consensus 17c
Reports Q4 revenue $163.4M, consensus $128.01M. Revenues for the quarter included $30.0M of intellectual property license revenue unrelated to key development programs. | |
|
|
|
|
|
|
